Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Antivir Chem Chemother ; 12(6): 367-73, 2001 Nov.
Article in English | MEDLINE | ID: mdl-12018682

ABSTRACT

Bovine viral diarrhoea virus (BVDV) is closely related to hepatitis C virus (HCV), and has been used as a surrogate virus in drug development for HCV infection. Similar to HCV, BVDV-encoded NS3 serine proteinase is responsible for multiple cleavages in the viral polyprotein, generating mature NS4A, NS4B, NS5A and NS5B proteins. NS3-dependent cleavage sites of BVDV contain a strictly conserved leucine at P1, and either serine or alanine at P1'. The full length BVDV NS3/4A serine protease has been cloned and expressed in bacterial cells. The enzyme has been purified from the soluble portion of Escherichia coli via a two-step purification procedure employing chromatography on heparin resin and gel filtration. The protease activity was characterized using in vitro translated BVDV NS4A/B and NS5A/B polyprotein substrates. A boronic acid analogue of the BVDV NS4A/NS4B cleavage site was synthesized and shown to be an efficient inhibitor of the NS3 serine protease in vitro. The compound, designated DPC-AB9144-00, inhibited approximately 75% of the NS3/4 activity at 10 microM with the NS4A/B substrate. However, no antiviral activity was detected with DPC-AB9144-00 in BVDV-infected Madin-Darby bovine kidney cells at concentrations as great as 90 pM, suggesting permeability or that other cellular-derived limitations were present.


Subject(s)
Boron/chemistry , Diarrhea Viruses, Bovine Viral/enzymology , Molecular Mimicry , Peptides/pharmacology , Serine Endopeptidases/metabolism , Serine Proteinase Inhibitors/chemistry , Serine Proteinase Inhibitors/pharmacology , Animals , Binding, Competitive , Blotting, Western , Cattle , Cell Line , Diarrhea Viruses, Bovine Viral/drug effects , Diarrhea Viruses, Bovine Viral/genetics , Diarrhea Viruses, Bovine Viral/physiology , Dose-Response Relationship, Drug , Peptides/chemistry , Protein Processing, Post-Translational/drug effects , Serine Endopeptidases/isolation & purification , Virus Replication/drug effects
4.
Appl Environ Microbiol ; 60(9): 3405-8, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7944372

ABSTRACT

The 3,500-bp pap operon in the 8,877-bp plasmid pSMB74 contains a cluster of four genes, papABCD, of which papA encodes prepediocin (A. M. Motlagh, M. Bukhtiyarova, and B. Ray, Lett. Appl. Microbiol. 18:305-312, 1994). The cluster without the promoter was cloned in the shuttle vector pHPS9. An Escherichia coli strain and a pediocin-sensitive Pediococcus acidilactici strain transformed with the recombinant plasmid, pMBR1.0, produced pediocin AcH. Deletion analysis by introducing mutations in the four genes in pMBR1.0 revealed that only papA and papD were required for pediocin AcH production and that the gene product of papD has both translocation and processing functions. In the transformed minicells of E. coli chi 925 the proteins of the pap cluster were synthesized, indicating no polar effect due to deletion.


Subject(s)
Bacteriocins/genetics , Genes, Bacterial , Multigene Family , Pediococcus/genetics , Cloning, Molecular , Escherichia coli/genetics , Gene Deletion , Gene Expression , Genetic Vectors , Pediocins , Plasmids/genetics , Restriction Mapping
5.
Lett Appl Microbiol ; 18(6): 305-12, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7764941

ABSTRACT

Several Pediococcus acidilactici strains produce a plasmid-encoded bacteriocin, pediocin AcH. Previous studies have shown that this plasmid, designated as pSMB 74, encodes genes associated with the production of prepediocin, its post-translation processing to pediocin AcH, transmembrane translocation of these molecules, and immunity of producer cells against pediocin AcH. We report here the complete nucleotide sequence of pSMB 74. The plasmid has a total of 8877 bp. Four genes have been located on pSMB 74. The genes are arranged in a gene cluster of 3500 bp and share a common promoter and rho-independent stem-loop terminator. The four genes, each with independent ribosome binding sites (rbs), initiation and termination codons and spacer sequences in between, were designated as pap A, pap B, pap C and pap D and encode respectively for proteins of 62, 112, 174 and 724 amino acids. The results of this study can be useful either to introduce a suitable marker at a unique restriction site in pSMB 74 and use it as a vector or to clone the pap gene cluster in a suitable plasmid and transform desirable strains for pediocin AcH production. The gene sequence has been submitted to Gene Bank (Acc. No. U02482).


Subject(s)
Bacteriocins/genetics , Pediococcus/genetics , Plasmids/genetics , Amino Acid Sequence , Base Sequence , Biotechnology , Chromosome Mapping , Genes, Bacterial , Molecular Sequence Data , Pediocins
6.
Anal Biochem ; 227(1): 148-55, 1995 May 01.
Article in English | MEDLINE | ID: mdl-7668375

ABSTRACT

The 28-kDa protease from human cytomegalovirus (hCMV) has been successfully cloned, expressed, and purified to homogeneity. An internally quenched fluorescent substrate (4-4'-dimethylaminophenazo)benzoyl-Arg-Gly-Val-Val-Asn-Ala-Ser-Ser -Arg-Leu-Ala-5-[(2'-aminoethyl)-amino]-naphthalene-1-sulfonic acid; DABCYL-CMV-EDANS) based on the maturational cleavage site (M-site) junction was synthesized in an effort to develop a fluorescence-based assay. This substrate is cleaved specifically between the Ala-Ser peptide bond thereby liberating the C-terminal peptide-EDANS fragment from the proximity quenching effect of the DABCYL group. This results in greater than a 10-fold increase in fluorescence that is observed at the EDANS emission wavelength of 495 nm. Human CMV protease efficiently cleaved this synthetic substrate permitting continuous assay at peptide concentrations lower than 10 microM. At substrate concentrations greater than 10 microM, linearity was lost due to the "inner filter effect." This represents the first fluorescence-based assay for any of the herpes virus proteases. Additionally, a peptidyl inhibitor, H-Arg-Gly-Val-Val-Asn-Ala-psi[CH2NH]-Ser-Ser-Arg-Leu-Ala-OH, was prepared. This inhibitor was also based on the same M-site cleavage junction with a nonhydrolyzable reduced peptide bond incorporated at the cleavage site. Using the fluorescence-based assay, this reduced peptide bond analog was observed to be an inhibitor of hCMV protease with an inhibition constant of > 500 microM.


Subject(s)
Cytomegalovirus/enzymology , Endopeptidases/analysis , Fluorescence , Fluorescent Dyes/chemistry , Naphthalenesulfonates/metabolism , Oligopeptides/metabolism , Viral Proteins/analysis , Amino Acid Sequence , Cloning, Molecular , Endopeptidases/genetics , Endopeptidases/metabolism , Escherichia coli/metabolism , Humans , Kinetics , Molecular Sequence Data , Naphthalenesulfonates/chemical synthesis , Oligopeptides/chemical synthesis , Oligopeptides/chemistry , Protease Inhibitors/chemistry , Protease Inhibitors/metabolism , Spectrometry, Fluorescence , Time Factors , Viral Proteins/genetics , Viral Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL